Assessment of Serum Uric Acid Levels According to Sex and Stage for Patients with Alzheimer-type Dementia
Journal Title: Turkish Journal of Neurology - Year 2019, Vol 25, Issue 2
Abstract
Objective: The aim of this study was to identify serum uric acid (UA) concentrations according to disease stage in patients with Alzheimer-type dementia (AD), and to collect data related to the hypothesis that oxidative stress is effective on the etiopathogenesis and progression of disease stage. Materials and Methods: The study was conducted with 180 patients who were categorized into disease stages in accordance with the Clinical Dementia Rating Scale (CDR) and 150 healthy individuals of the same age group. In our retrospective study, patients who showed more than one cognitive deficit and diagnosed with possible AD according to the diagnostic criteria of National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders Association were administered the CDR, Mini-Mental Test (MMSE), Geriatric Depression Rating Scale (GDRS), and individuals in the control group were administered the MMSE and GDRS. Venous blood samples for biochemical studies were collected after 12-14 hours of fasting in the patient and control groups. Results: In patients diagnosed as having AD, it was found that there was a statistically significant increase in age and duration of disease parallel with the progression of disease stages, and a decrease in UA and albumin concentrations in both males and females (p<0.05). Conclusion: Our study supports the hypothesis that the decrease detected in serum UA concentrations in parallel with the progression of disease stages is directly related to the pathogenesis of AD. For the identification of chronic progressive diseases such as AD and to take precautions, the identification of variations in easily accessible and low-cost parameters such as serum albumin and UA concentrations in the early stages becomes important. In future years, when neuroprotective and neuro-restorative treatment options are available, identification of serum UA values as a marker of disease progression and knowledge of the association between serum UA concentrations and disease stage in our data will guide and support research into disease etiology.
Authors and Affiliations
Tamer Yazar1, Hülya Olgun Yazar
Keywords
Related Articles
- EP ID EP48810
- DOI 10.4274/tnd.galenos.2019.85698
- Views 390
- Downloads 0
Post Blood Transfusion Reversible Cerebral Vasoconstriction with Posterior Leukoencephalopathy Syndrome
Reversible Cerebral Vasoconstriction syndrome is an uncommon and often under-diagnosed neurologic disorder. It is characterized by thunderclap headache with or without focal neurologic deficits and seizures. Common provo...
Stiff Person Syndrome-The Less Common Antibody: A Case Report
Stiff Person syndrome (SPS) is a rare, disabling syndrome characterized by progressive muscle stiffness and axial rigidity. It may have an autoimmune, paraneoplastic or cryptogenic etiology. A 59-year-old woman presented...
Correlation of Hematological Parameters, Imaging Results, and Clinical Findings in Primary Headache Disorders
Objective: Headache is the most common and challenging neurologic problem in society. There is a relationship between hematologic parameters and headache disorders. White matter lesions are known to be common in migraine...
Transient Encephalopathy with A Single Dose of Oral Metronidazole: A Case Report
Metronidazole (MNZ) is an antibacterial agent widely used in the treatment of anaerobic and protozoal infections, easily penetrating the cerebrospinal fluid and central nervous system. MNZ is well-tolerated, but it can a...
Factors Predicting Falls in Parkinson’s Disease: Investigation of Motor, Non-motor Findings and Different Dual Task Activities
Objective: The purpose of this study was to identify the predictors of future falls in mild-to-moderate stage Parkinson’s disease (PD) without cognitive impairment. We evaluated motor findings, non-motor findings, and di...